Regulatory Requirements for Development and Filing of Generic Drugs Globally on Comprehensive Studies

Raju Rastogi

doi:10.4172/2278-0238.1000109

ISSN: 2278-0238

International Journal of Research and Development in Pharmacy & Life Sciences
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Perspective
Int J Res Dev Pharm L Sci,
DOI: 10.4172/2278-0238.1000109

Regulatory Requirements for Development and Filing of Generic Drugs Globally on Comprehensive Studies

Raju Rastogi^*: Department of Clinical Biochemistry, Cristian Medical College, Vellore, Tamil Nadu, India

^*Corresponding Author : Raju Rastogi, Department of Clinical Biochemistry, Cristian Medical College, Vellore, Tamil Nadu, India, Email: rastogir@gmail.com

Received Date: Oct 05, 2021 / Accepted Date: Oct 19, 2021 / Published Date: Oct 26, 2021

View PDF Download PDF

Citation: Rastogi R (2021) Regulatory Requirements for Development and Filing of Generic Drugs Globally on Comprehensive Studies. Int J Res Dev Pharm L Sci 7: 109. Doi: 10.4172/2278-0238.1000109

Copyright: © 2021 Rastogi R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.